Chun Bao Yang
Directeur/Membre du Conseil chez SHANGHAI QINGPU FIRE-FIGHTING EQUIPMENT CO., LTD.
Postes actifs de Chun Bao Yang
Sociétés | Poste | Début | Fin |
---|---|---|---|
SHANGHAI QINGPU FIRE-FIGHTING EQUIPMENT CO., LTD. | Directeur/Membre du Conseil | 01/10/2000 | - |
Independent Dir/Board Member | 01/10/2000 | - | |
Shanghai Huashen Certified Public Accountants Ltd. | Corporate Officer/Principal | 01/11/1973 | - |
Historique de carrière de Chun Bao Yang
Anciens postes connus de Chun Bao Yang
Sociétés | Poste | Début | Fin |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Directeur/Membre du Conseil | 12/09/2014 | 20/05/2016 |
Independent Dir/Board Member | 12/09/2014 | 20/05/2016 |
Formation de Chun Bao Yang
Madonna University | Graduate Degree |
Statistiques
Internationale
Hong Kong | 3 |
Etats-Unis | 2 |
Chine | 2 |
Opérationnelle
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Graduate Degree | 1 |
Sectorielle
Electronic Technology | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SHANGHAI QINGPU FIRE-FIGHTING EQUIPMENT CO., LTD. | Electronic Technology |
Entreprise privées | 2 |
---|---|
Shanghai Huashen Certified Public Accountants Ltd. | |
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
- Bourse
- Insiders
- Chun Bao Yang
- Expérience